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A B S T R A C T
Purpose: To estimate the prevalence of active epilepsy in adults in an established demographic
surveillance site in rural Tanzania. To describe the clinical characteristics of epilepsy and to estimate the
treatment gap in this population.
Methods: A pilot study established that a previously validated screening questionnaire was sensitive for
detecting cases of epilepsy in a Kiswahili-speaking Tanzanian population. A door-to-door census of the
adult population (total 103,026) used the screening questionnaire to identify possible cases of epilepsy,
who were then assessed by a research doctor to establish a diagnosis of epilepsy or otherwise. The
prevalence of active epilepsy in this population was estimated with age-standardisation to the WHO
standard population. Seizure types and epilepsies were classiﬁed according to current recommendations
of the International League Against Epilepsy. The treatment gap for epilepsy was estimated based on
antiepileptic drug use as reported by cases.
Results: Two hundred and ninety-one cases of active epilepsy, all with convulsive seizures, were
identiﬁed. The age-standardised prevalence was 2.91/1000 adults (95% CI 2.58–3.24); the crude
prevalence adjusted for non-response was 3.84/1000 adults (95% CI 3.45–4.20). Focal-onset seizures
accounted for 71.5% of all cases identiﬁed. The treatment gap was 68.4% (95% CI 63.0–73.7).
Conclusions: This is one of the largest community-based studies of the prevalence of epilepsy in adults
conducted in sub-Saharan Africa to date. We identiﬁed a lower prevalence than has previously been
described in this region. The high proportion of focal onset seizures points to a large burden of acquired, and
possibly preventable, epilepsy in this population. A treatment gap of 68.4% conﬁrms that interventions to
raise awareness of the treatable nature of epilepsy are warranted in this and similar populations.
 2012 British Epilepsy Association. Published by Elsevier Ltd.   
Contents lists available at SciVerse ScienceDirect
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1.1. Background
Epilepsy accounts for up to 1% of the global burden of disease.2
An estimated 32.7 million people suffer from active epilepsy
worldwide,3 with 80% or more of people with epilepsy (PWE) living* Corresponding author at: Department of Infection and Tropical Medicine, Elliott
Building, Royal Victoria Inﬁrmary, Newcastle-upon-Tyne, NE1 4LP, United
Kingdom. Tel.: +44 0 191 282 9751; fax: +44 0 191 282 0810.
E-mail address: ewanh7@gmail.com (E. Hunter).
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Open access unin low and middle income countries (LMICs).4 A further 500 million
people (including families and carers of PWE) are thought to be
indirectly affected by epilepsy.5 It is generally accepted that the
incidence, prevalence and mortality associated with epilepsy are all
higher in LMICs than in high income countries (HICs), although
estimates have varied widely and ﬁndings from different studies are
difﬁcult to compare due to differing inclusion criteria, clinical
deﬁnitions and the difﬁculties associated with establishing reliable
baseline demographic data.3,6–9 While up to four-ﬁfths of the
potential market for anti-epileptic drugs (AEDs) is in LMICs, 90% or
more of PWE in these countries may receive no treatment at all.5,10,11
The proportion of PWE who require treatment but who are not
receiving it is known as the treatment gap (TG).12der CC BY-NC-ND license. 
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We conducted a door-to-door survey in an established
demographic surveillance site (DSS) in rural Tanzania. We sought
to estimate the prevalence of active epilepsy, to describe the
pattern of epilepsy and to quantify the TG in this population. With
a total denominator population of 161,119, this is one of the largest
community-based epidemiological studies of epilepsy to be
conducted in sub-Saharan Africa (SSA) to date. Paediatric and
adult studies were conducted in parallel. Findings from the
paediatric population have been published elsewhere13; we report
here on ﬁndings in the adult population, deﬁned as individuals
aged 15 years and above.
2. Methods
2.1. Study design
A door-to-door census of the entire DSS population was
completed between January and June 2009 and a previously
validated screening questionnaire was used to detect possible
cases of epilepsy.1 The questionnaire was forward and back
translated between English and Kiswahili (KS) and a pilot study
was conducted to assess the questionnaire’s sensitivity for cases of
epilepsy in a KS-speaking Tanzanian population. Volunteers for the
pilot study included patients with and without epilepsy at
Muhimbili National Hospital, Dar es Salaam, and locally at
Kilimanjaro Christian Medical Centre (KCMC), Moshi. During
preparations for the census, all enumerators received training in
the identiﬁcation of likely cases of epilepsy and were also involved
in focus group discussions of each item in the screening
questionnaire, with further reﬁnements to the KS translation
being made to optimise its utility in the ﬁeld. Details of the
screening questionnaire and KS translation are given in Appendix.
2.2. Study setting
The Hai district lies on the slopes of Mount Kilimanjaro in
northeast Tanzania, covering an area of approximately 13,000 km2.
Villages are served by a network of unpaved roads of varying
quality, many of which are impassable to motorised vehicles
during the twice-yearly rainy seasons. Agriculture, livestock
keeping, dairy farming, commercial mining and cottage industries
are the main economic activities.14 Facilities for Electroencepha-
lography (EEG) and computed tomography (CT) are available at
KCMC, a large referral hospital in the nearby town of Moshi.
Hai was established as one of three DSSs in Tanzania by the
Adult Morbidity and Mortality Project (AMMP), an epidemiological
programme funded by the UK Department for International
Development and conducted in partnership between the Tanza-
nian Ministry for Health and Newcastle University, UK.15 Between
1992 and 2004 the population of each DSS was enumerated by an
annual census, with all households and household members being
assigned unique identifying numbers. The DSS infrastructure in
Hai has subsequently been maintained through a series of
epidemiological studies, and there is currently at least one trained
census enumerator per village.16–21 These enumerators facilitate
access to their communities by visiting researchers and are
coordinated by a team of supervisors who are employed in clinical
posts by the district health authority.
2.3. Participants and data sources
All individuals who responded positively to the screening
questionnaire at census were assessed in detailed by a research
doctor trained in the diagnosis of epilepsy (EH). In addition,enumerators were also asked to identify any individuals within
their communities who they knew, or suspected, suffered from a
seizure disorder. Finally, results of a contemporaneous study
utilising data from the same census to screen for neurological
disability, including epilepsy, in 2232 individuals aged over 70
provided further cases.21 A collateral history was sought in all
instances to aid in diagnosis and classiﬁcation of seizures. To be
included in the study people diagnosed with epilepsy had to
be alive and resident in the district on the prevalence date. The age
cut-off for adults of 15 years and above was chosen to reﬂect local
practice in terms of whether individuals are managed by adult or
paediatric medical services.
2.4. Variables
All individuals diagnosed with epilepsy were interviewed in depth
to establish seizure history, possible risk factors, treatment history
and socio-demographic features. The interview format was drawn
from the clinical experience of the research team and from previous
ﬁeld work experience in this study population.16,18,22 A semi-
structured element was included to facilitate subsequent review and
validation of diagnoses.23 All cases were offered further investigation
with CT head scan and EEG. CT scans were reported locally to exclude
any acute pathology, and then reviewed by neuroradiologists in the
UK (DB, AI). There are no facilities for interpreting EEGs locally and all
recordings were read in the UK by a consultant neurophysiologist
(RGW). Any individuals identiﬁed with epilepsy who were not being
treated adequately were started on treatment and referred to services
locally for follow-up. Clinical details and investigation ﬁndings for all
patients were reviewed by a consultant neurologist in the UK with an
interest in epilepsy (MJ). CT and EEG ﬁndings were correlated with
clinical details to classify epilepsies according to currently accepted
criteria.24,25 Active epilepsy was deﬁned as at least two unprovoked
seizures occurring at least 24 h apart, with the most recent seizure
occurring within the 5 years prior to the prevalence date of 1st of
June 2009. Individuals who did not satisfy these criteria, but who
were maintained on AEDs for an appropriate indication, were also
considered to have active epilepsy. Estimates for the TG were based
on individuals who reported either no or inadequate AED therapy at
the time of the study.
All data were entered into Microsoft Excel 2007 as ﬁeld work
progressed and then re-entered into Microsoft Access 2007, with
any discrepancies being corrected with reference to the original
case notes.
2.5. Statistical methods
Statistical analyses were performed using SPSS-17 for Windows
(SPSS, Chicago, IL, USA). Age- and sex-speciﬁc prevalence rates for
the Hai adult population were calculated in ﬁve-year age-bands.
Prevalence was age-standardised to the WHO world standard
population using the direct method26; 95% conﬁdence intervals
(CIs) were calculated based on the assumptions of the binomial
distribution. As this study is concerned only with individuals aged
15 years and above, the Hai and WHO populations were weighted
accordingly (Table 5). To look for any evidence of clustering, one-
way analysis of variance (ANOVA) was used to compare normally
distributed mean prevalences from administrative divisions
within the district.
3. Results
3.1. Pilot study
Forty-nine subjects (27 cases of epilepsy and 22 controls) were
recruited into the pilot study. The KS translation of the screening
Table 1
Response rates to individual screening questions.
Question Positive
responses
n (%)
1 Have you ever had attacks of shaking of the arms
or legs which you could not control?
259 (45.6)
2 Have you ever had attacks in which you fall suddenly,
without any reason, changing colour in the palms,
lips or face?
363 (63.9)
3 Have you ever lost consciousness? 362 (63.7)
4 Have you ever had attacks in which you fall with loss
of consciousness?
316 (55.6)
5 Have you ever had attacks in which you fall and bite
your tongue?
213 (37.5)
6 Have you ever had attacks in which you fall and lose
control of your bladder?
177 (31.2)
7 Have you ever had brief attacks of shaking or trembling
in one arm or leg or in the face?
200 (35.2)
8 Have you ever had attacks in which you lose contact
with the surroundings or experience abnormal smells?
152 (26.8)
9 Have you ever been told that you have or have had
convulsions, epilepsy or epileptic ﬁts?
173 (30.5)
Fig. 1. Hai DSS adult population structure (2009 census).
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ﬁcity, with positive and negative predictive values (PPV, NPV) of
73% and 100% respectively.
3.2. Participants
The 2009 census identiﬁed a total population of 161,119, of
whom 103,026 (63.9%) were aged 15 years and over (54,386
female, 48,640 male) (Fig. 1). Five hundred and sixty-eight adult
individuals (286 female, 282 male) responded positively to the
screening questionnaire. Response rates to individual questions
are given in Table 1. Three hundred and ninety-ﬁve (69.5%) of these
were clinically assessed, with a diagnosis of active epilepsy being
made in 209 (PPV 52.9%). Of the 173 individuals that were not
available for assessment, 29 (16.8%) had moved or travelled from
the district at the time of the study, 21 (12.1%) could not be traced,
18 (10.4%) refused, 12 (6.9%) had died since the census (four deaths
prior to the prevalence date) and four (2.3%) were accounted for by
data entry errors (duplicate names or wrong dates of birth). A
further 89 (51.4%) did not attend for assessment on two or more
occasions. In addition to census responders, a further 130
individuals (60 female, 70 male) identiﬁed by village enumerators
as possible cases were assessed, with active epilepsy being
diagnosed in 80 (61.5%). The concurrent study of neurological
disability in the elderly identiﬁed ﬁve cases of active epilepsy, ofFig. 2. Summary of cawhich one was identiﬁed independently by the epilepsy study,
with a further two being available for assessment and inclusion in
the ﬁnal case series. Epilepsy was suspected in a further 14
individuals, although insufﬁcient history was obtained, either
directly or from an eye witness, to conﬁrm the diagnosis. These
individuals remain under follow-up. In summary, 527 individuals
were assessed clinically with 291 cases of active epilepsy being
identiﬁed (Fig. 2). An eye witness was available in 202 (69.4%) of
291 conﬁrmed cases. CT head scans were available in 200 (68.7%)
of 291 conﬁrmed cases, with cerebral abnormalities on 51 (25.5%)
scans. EEGs were available from 216 (74.2%) of 291 cases, with
abnormalities consistent with epilepsy seen in 84 (38.9%)
recordings. CT and EEG ﬁndings are summarised in Tables 2 and 3.
3.3. Clinical features and treatment history
All 291 cases identiﬁed were suffering from active epilepsy with
convulsive seizures (AEWCS). Focal onset seizures were identiﬁedse ascertainment.
Fig. 3. Relative contributions of diagnostic modalities to identifying focal-onset
seizures in Hai.
Table 2
Abnormalities on CT scans.
CT scan ﬁnding n (%)
Vascular 13 (25.5)
Cysticercosis 8 (15.7)
Trauma 5 (9.8)
Encephalomalacia 5 (9.8)
Ventricular dilatation 5 (9.8)
Hemispheric atrophy 4 (7.8)
Hydrocephalus 3 (5.9)
Lobar atrophy 3 (5.9)
Tumour 2 (3.9)
Generalised atrophy 1 (2.0)
Lobar calciﬁcation 1 (2.0)
Porencephalic cyst 1 (2.0)
Total 51 (100)
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cases, with seizures remaining unclassiﬁed in 76 (26.1%) cases. Six
(85.7%) of seven cases with generalised onset seizures had EEGs
suggestive of genetic generalised epilepsy, two of which could be
sub-classiﬁed as juvenile myoclonic epilepsy. Sixty-eight (32.7%)
of 208 cases with focal onset seizures were classiﬁed as structural/
metabolic. Epilepsy remained unclassiﬁed in 274 (74.6%) of 291
cases: 140 (67.3%) of 208 focal cases, one (14.3%) of seven
generalised cases, and in all 76 cases (100.0%) in which seizures
could not be classiﬁed (Table 6). The relative contributions of
diagnostic modalities to identifying focal onset seizures are
illustrated in Fig. 3.
Two-hundred and ﬁfty-three (86.9%) of 291 cases had
previously sought medical attention for their seizures, of whom
122 (48.2%) reported using AEDs at the time of the study. Of these,
30 (24.6%) were using doses likely to be sub-therapeutic, based on
published prescribing information27,28 and guidance on managing
epilepsy in resource-poor settings.29 Ninety-two (31.6%) of 291
cases were therefore considered as adequately treated with AEDs
at the time of the study.
3.4. Prevalence and treatment gap
The crude prevalence of AEWCS in the Hai adult population on
1st June 2009 was 2.82 per 1000 adults (95% CI 2.50–3.15). Age-
and sex-speciﬁc prevalence rates are given in Table 4. The crude
prevalence was higher in males than in females (difference in
proportions 0.69/1000; 95% CI 0.03–1.34). To accommodate small
numbers in the older population, cases aged 70 years or more were
combined into a single age band of 70+ prior to age-standardisa-
tion (Table 5). The age-standardised prevalence of AEWCS in the
adult Hai population was 2.91 per 1000 adults (95% CI 2.58–3.24).
After accounting for deaths prior to the prevalence date and data
entry errors, a further 165 (95.4%) of the 173 individuals who
screened positive during the census but who were not assessed
clinically were potentially eligible for the study. Applying the PPV
of 52.9% for detection of active epilepsy by the screening
questionnaire, an additional 87 cases may have been missed,
which would bring the total number of active cases to 378 (crude
prevalence 3.67 per 1000; 95% CI 3.3–4.0). Diagnoses wereTable 3
Abnormalities on EEG.
EEG ﬁnding n (%)
Temporal lobe abnormalities 27 (32.1)
Non-epileptiform abnormalities 25 (29.8)
Extra-temporal focal abnormalities 16 (19.0)
Multifocal epileptiform abnormalities 10 (11.9)
Generalised epileptiform abnormalities 6 (7.1)
Total 84 (100)deferred in 14 individuals and two cases identiﬁed by the other
study were not available for assessment by the epilepsy study
team. A conﬁrmed diagnosis in these 16 would bring the total case
series to 394 (crude prevalence 3.82 per 1000; 95% CI 3.45–4.20).
While the prevalence of epilepsy varied from village to village
(0–6.24/1000), there were no signiﬁcant differences in mean
prevalence between the ﬁve administrative divisions within the
district (ANOVA, p = 0.991).
A conservative estimate of the TG for epilepsy in the adult Hai
population, based on AED use, was 68.4% (95% CI 63.0–73.7).
4. Discussion
4.1. Key results and interpretation
This study is one of the largest community-based surveys of the
prevalence of epilepsy in an adult population to be conducted in
SSA to date. The age-standardised prevalence for AEWCS in adults
of 2.91/1000 (95% CI 2.58–3.24), with crude prevalence adjusted
for non-response of 3.84/1000 (95% CI 3.47–4.22), is considerably
lower than both the median prevalence of 15/1000 previously
reported from SSA9 and the range for active prevalence of 8–10/
1000 previously reported from Tanzania.30–32 It is, however, in line
with a recent study of comparable size and design in a rural Kenyan
population which found a crude prevalence of 2.9/1000 (95% CI
2.6–3.2), rising to 4.5/1000 (95% CI 4.1–4.9) after adjustment for
non-response and sensitivity.33 This latter study sought to identify
active convulsive epilepsy only, and the lower prevalence ﬁgures of
both studies may reﬂect this.
In community-based studies from SSA heterogeneity of
prevalence within study populations has been frequently ob-
served.9,31,33 Whether this reﬂects clustered exposure to environ-
mental or genetic risk factors or a tendency for PWE to live closer to
locally available treatment services remains unclear. In our study
case ascertainment was grossly uniform across administrative
divisions, with no observation of clustering.
We found a higher prevalence in males than in females,
although the difference was marginal. A review of 19 studies of the
prevalence in SSA in which data on gender were available found a
mean ratio of males to females of 1.4, although the ratio was
signiﬁcantly different in only a quarter of studies.9 It has been
suggested that a higher prevalence of epilepsy in males in Tanzania
may reﬂect a higher risk of cranial trauma through a tendency to
Table 4
Age- and sex-speciﬁc prevalence of epilepsy in adults in Hai.
Female Male Total
Age-band
(years)
Cases
(n)
Denominator
population (n)
Prevalence
per 1000 (95% CI)
Cases
(n)
Denominator
population (n)
Prevalence per
1000 (95% CI)
Cases
(n)
Denominator
population (n)
Prevalence per
1000 (95% CI)
15–19 23 8114 2.83 (1.68–3.99) 19 8648 2.20 (1.21–3.18) 42 16,762 2.51 (1.75–3.26)
20–24 25 5225 4.78 (2.91–6.66) 36 4719 7.63 (5.15–10.11) 61 9944 6.13 (4.60–7.67)
25–29 23 5487 4.19 (2.48–5.90) 14 4467 3.13 (1.49–4.77) 37 9954 3.72 (2.52–4.91)
30–34 12 5381 2.23 (0.97–3.49) 18 4961 3.63 (1.96–5.30) 30 10,342 2.90 (1.86–3.94)
35–39 9 5216 1.73 (0.60–2.85) 13 4852 2.68 (1.22–4.13) 22 10,068 2.19 (1.27–3.10)
40–44 10 4800 2.08 (0.79–3.37) 17 4234 4.02 (2.11–5.92) 27 9034 2.99 (1.86–4.11)
45–49 13 4156 3.13 (1.43–4.83) 11 3630 3.03 (1.24–4.82) 24 7786 3.02 (1.85–4.31)
50–54 7 3727 1.88 (0.49–3.27) 7 2986 2.34 (0.61–4.08) 14 6713 2.09 (0.99–3.18)
55–59 6 2911 2.06 (0.41–3.71) 8 2437 3.28 (1.01–5.55) 14 5348 2.62 (1.25–3.99)
60+ 8 9369 0.85 (0.26–1.45) 12 7706 1.56 (0.68–2.44) 20 17,075 1.17 (0.66–1.68)
Total 136 54,386 2.50 (2.08–2.92) 155 48,640 3.19 (2.69–3.69) 291 103,026 2.82 (2.50–3.99)
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studies from Tanzania have found higher proportions of females
with epilepsy.30,31 It has been postulated that this may be
accounted for by a higher mortality rate among males, again
because of dangerous occupations,31 although Tanzania is a
country with a high maternal mortality rate, and the strength of
this argument could be questioned.34 It has been observed that
women in one study population were more health-conscious then
men, being accustomed to attending maternity and child-care
clinics and speaking openly about health issues, possibly
contributing to higher ascertainment rates in women.30 Overall
there remains no clear consensus on whether observed gender
differences in the prevalence of epilepsy in SSA are due to gender-
speciﬁc aetiological factors, bias arising through artefact in case-
ascertainment or competing mortality risks.35
Studies from Europe and the USA have identiﬁed peaks in
the incidence of epilepsy in young children and in the
elderly.36–38 We did not ﬁnd a peak in prevalence in those
aged 60 and older, although this age group represents only
10.6% of the total Hai population, and it is difﬁcult to draw
comparisons with populations from HICs which have very
different population structures. We did ﬁnd a peak in
prevalence in those aged 20–24 years (6.13/1000), with a
concentration of male cases in this age group (crude prevalence
in males 7.63/1000). This is in keeping with a higher prevalence
in adolescents and young adults identiﬁed by other studies in
rural SSA.9,30–33 Whether the lower prevalence in later adult life
points to early mortality or spontaneous remission remains
unclear.33 A similar distribution in both the active and lifetime
prevalence of epilepsy has been observed in Tanzania,Table 5
Age distributions of Hai and WHO standard populations, weighted for adults (15 yea
Age band (years) Hai population (% of total) Hai adult
0–14 58,093 (36.1) – 
15–19 16,762 (10.4) 16.3 
20–24 9944 (6.2) 9.7 
25–29 9954 (6.2) 9.7 
30–34 10,342 (6.4) 10.0 
35–39 10,068 (6.3) 9.8 
40–44 9034 (5.6) 8.8 
45–49 7786 (4.8) 7.6 
50–54 6713 (4.2) 6.5 
55–59 5348 (3.3) 5.2 
60–64 4339 (2.7) 4.2 
65–69 3867 (2.4) 3.8 
70+ 8869 (5.5) 8.6 
All-ages 161,119 (100.1)a – 
Adults 103,026 (63.9) 100.2a
a Percentages may not add up to 100% because of rounding.suggesting that those in remission may not report their
previous seizures.31,39 Conversely, there is mounting evidence
of early mortality in epilepsy in LMICs, in excess of that seen in
HICs.40 Observational data suggest that this is likely to be the
case in SSA,41–43 although there are very few formalised data
with comparable standardised mortality ratios.43
All PWE identiﬁed in our study had AEWCS, with focal-onset
seizures accounting for 71.5% of all cases. High rates of focal onset
seizures were found in 71% of all cases identiﬁed in a
recent community-based study of people with AEWCS in Kenya,44
and in 55% of all cases in a community-based study from Nigeria,
although it is not clear how focal seizures with generalised clonic
movements were classiﬁed in this latter study.45 Conversely,
higher rates of generalised-onset seizures have previously been
reported from community-based studies in SSA, accounting for
between 58% and 82% of diagnoses.31,32,46 Differing approaches to
case-ascertainment, differing diagnostic and classiﬁcation criteria,
and lack of EEG and CT to aid with classiﬁcation make a strict
comparison between studies difﬁcult, although all authors
comment that focal seizures becoming rapidly generalised may
have erroneously been classiﬁed as generalised onset seizures. The
high rate of focal onset seizures identiﬁed in our study suggests
that a high proportion of epilepsy in this population may be due to
identiﬁable, and possibly preventable, causes. We know that
epilepsy in children from Hai is associated with adverse perinatal
events13, while exposure to Taenia solium, the parasitic infection
responsible for neurocysticercosis (NCC), is associated with
epilepsy in a number of African populations,47 including Tanza-
nia.48,49 The role that this latter aetiology might play in an area
where the prevalence of epilepsy is low, such as Hai, is not clear,rs).
 weighted (%) WHO (%) WHO adult weighted (%)
26.2 –
8.5 11.5
8.2 11.1
7.9 10.7
7.6 10.3
7.2 9.7
6.6 8.9
6.0 8.2
5.4 7.3
4.6 6.2
3.7 5.0
3.0 4.0
5.3 7.2
100.2a –
– 100.1a
Table 6
Classiﬁcation of epilepsies in adult PWE in Hai district, Tanzania.
Final classiﬁcation n (%)
Focal – structural/metabolic 678 (23.4)
Focal – unclassiﬁed 140 (48.1)
Generalised – GGEa 4 (1.4)
Generalised – JMEb 2 (0.7)
Generalised – unclassiﬁed 1 (0.3)
Unclassiﬁed convulsive epilepsy 76 (26.1)
Total 291 (100.0)
a GGE – Generalised Genetic Epilepsy.
b JME – Juvenile Myoclonic Epilepsy.
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warranted.
The TG for epilepsy in the Hai population, based on reported use of
adequate and appropriate AED therapy, was 68.4% (95% CI 63.0–
73.7). This is lower than previous estimates of TG in Tanzania of
between 76% and 95.8%,30,32 although is in line with more recent
systematic reviews of TG in developing countries worldwide.12,50The
lower TG in Hai could be explained by the relative proximity to a large
referral hospital (KCMC) and to the nearby large towns of Arusha and
Moshi, where numerous private clinics and non-governmental
healthcare providers are located. Conversely, we know that there is a
high degree of stigma associated with epilepsy in this population,20
and more stigmatised and marginalised individuals may not have
presented to the study. It can be assumed that such individuals would
be less likely to be treated, and would therefore contribute to the
estimate of TG if they were known.
4.2. Limitations
While a small pilot study established the sensitivity of the
screening tool in a KS-speaking Tanzanian population, a ﬁeld-
based validation study with complete ascertainment in a larger
sample would have facilitated a sensitivity analysis of the
screening questionnaire and would also have allowed us to
comment on the likely prevalence of non-convulsive epilepsies,
given that these were not detected by our screening protocol.
Epilepsy with non-convulsive seizures can account for up to 50% of
all epileptic disorders in community-based studies, and the true
prevalence of all epilepsies in the Hai population may therefore
approach 6/1000.36,37
Only cases of generalised convulsive epilepsy were detected in
our study, despite the aim of detecting all seizure types.
Community-based studies from Zambia and Tanzania have also
made use of the same screening instrument, with modiﬁcations. In
Zambia, three additional questions were used to reduce the false-
positive rate due to detection of febrile and malaria-associated
seizures in children under the age of seven years.35 The paediatric
study from Hai excluded children under the age of six years for this
reason,13 and these additional questions were not used in our
study. In Tanzania, a 15-item questionnaire has been used,30
although results of this study were not available at the time of
planning and initiating our population census. We anticipated
difﬁculties with speciﬁc questions, particularly questions two and
eight (see Appendix), and sought to address these through focus
group work with census enumerators administering the question-
naire. The difﬁculties of identifying focal onset epilepsies without
secondary generalisation in community-based studies in SSA have
previously been acknowledged and reﬂected in study design.33
Based on our experience, it may be that this is a more realistic
approach for large-scale surveys conducted in SSA.
Nearly one third of individuals (30.5%) who responded
positively to the screening questionnaire were not available
for clinical assessment. While this decreases the internal validityof our study, and must be acknowledged as a limitation, Hai is an
established DSS, and this high rate of non-attendance may also
reﬂect the high degree of stigma associated with epilepsy in this
population.20 The use of capture-recapture techniques has
previously been used to maximise case ascertainment of non-
communicable diseases in a clinic-based setting in South
Africa,51 although has been less successful in community-based
settings in Tanzania, including Hai,52 and was not pursued in our
study.
While we report here on the prevalence in adults only, the
estimate has been age-standardised to facilitate comparison with
other studies. The crude prevalence in children over the age of six
years in the same population was 2.91 per 1000.13
5. Conclusions
Active epilepsy with convulsive seizures has a lower prevalence
in this part of Tanzania than elsewhere in SSA, and the previously
reported high prevalence rates for epilepsy in SSA cannot be
generalised to the whole region. The high proportion of focal onset
seizures points to a large burden of acquired, and possibly
preventable, epilepsy. The treatment gap of 68.4% conﬁrms that
interventions to improve the management of epilepsy in this
population are warranted. With a low prevalence, however,
improved outcomes are potentially achievable for the majority
of PWE in this and similar populations.
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Appendix A
Screening questionnaire used to detect possible cases of epilepsy,
adapted from Placencia et al.1 (Kiswahili translations in italics)
 1. Have you ever had attacks of shaking of the arms or legs which
you could not control?
Je, ulishawahi kupatwa na hali ya kutetemeka mikono au miguu
ambayo hukuweza kuizuia?
 2. Have you ever had attacks in which you fall suddenly, without
any reason, changing colour in the palms, lips or face?
Je, ulishawahi kupatwa na hali ambayo ilikufanya uanguke
kubadilika rangi na kuwa mweupe kwenye viganja, midomo na
usoni??
 3. Have you ever lost consciousness?
E. Hunter et al. / Seizure 21 (2012) 691–698 697Je, ulishawahi kupoteza fahamu?
 4. Have you ever had attacks in which you fall with loss of
consciousness?
Je, ulishawahi kupatwa na hali ambayo ilisababisha uanguke na
kupoteza fahamu?
 5. Have you ever had attacks in which you fall and bite your
tongue?
Je, ulishawahi kupatwa na hali iliyokusababisha uanguke na
kuuma/kung’ata ulimi wako?
 6. Have you ever had attacks in which you fall and lose control of
your bladder?
Je, ulishawahi kupatwa na hali ambayo ilikufanya uanguke na
kutoa mkojo?
 7. Have you ever had brief attacks of shaking or trembling in one
arm or leg or in the face?
Je, ulishawahi kupatwa na hali ya muda mfupi ya kutetemeka au
kutikisika mkono au mguu mmoja au kwenye uso?
 8. Have you ever had attacks in which you lose contact with the
surroundings and experience abnormal smells?
Je, ulishawahi kupatwa na hali ambayo ilikufanya upoteze
ufahamu wa mahali ulipo na kusikia harufu zisizo za kawaida?
 9. Have you ever been told that you have or had epilepsy or
epileptic ﬁts?
Je, ulishawahi kuelezwa kuwa una au ulishawahi kuwa na kifafa
au kuanguka kifafa?
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